日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN

谷氨酰胺酶抑制剂 CB-839 靶向 MPN 中 JAK2 突变造血的代谢依赖性

Marc Usart, Nils Hansen, Jan Stetka, Tiago Almeida Fonseca, Alexandre Guy, Quentin Kimmerlin, Shivam Rai, Hui Hao-Shen, Julien Roux, Stefan Dirnhofer, Radek C Skoda

Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm

抑制白细胞介素-1β可减轻JAK2-V617F驱动的骨髓增生性肿瘤小鼠的骨髓纤维化和骨硬化

Shivam Rai ,Elodie Grockowiak ,Nils Hansen ,Damien Luque Paz ,Cedric B Stoll ,Hui Hao-Shen ,Gabriele Mild-Schneider ,Stefan Dirnhofer ,Christopher J Farady ,Simón Méndez-Ferrer ,Radek C Skoda

JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality

JAK2-V617F 和干扰素-α 诱导以长期功能下降为特征的巨核细胞偏向干细胞

Tata Nageswara Rao, Nils Hansen, Jan Stetka, Damien Luque Paz, Milena Kalmer, Julian Hilfiker, Max Endele, Nouraiz Ahmed, Lucia Kubovcakova, Margareta Rybarikova, Hui Hao-Shen, Florian Geier, Christian Beisel, Stefan Dirnhofer, Timm Schroeder, Tim H Brümmendorf, Dominik Wolf, Steffen Koschmieder, Ra

Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia

针对人类 IL1RAP (IL1R3) 的抗体在急性髓系白血病异种移植模型中显示出治疗效果

Helena Ågerstam, Christine Karlsson, Nils Hansen, Carl Sandén, Maria Askmyr, Sofia von Palffy, Carl Högberg, Marianne Rissler, Mark Wunderlich, Gunnar Juliusson, Johan Richter, Kjell Sjöström, Ravi Bhatia, James C Mulloy, Marcus Järås, Thoas Fioretos

Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein

通过针对IL-1受体辅助蛋白的抗体靶向分离和杀死候选慢性粒细胞白血病干细胞

Marcus Järås, Petra Johnels, Nils Hansen, Helena Agerstam, Panagiotis Tsapogas, Marianne Rissler, Carin Lassen, Tor Olofsson, Ole Weis Bjerrum, Johan Richter, Thoas Fioretos